nodes	percent_of_prediction	percent_of_DWPC	metapath
Vinblastine—germ cell cancer—testicular cancer	0.191	0.353	CtDrD
Vinblastine—kidney cancer—testicular cancer	0.178	0.329	CtDrD
Vinblastine—lung cancer—testicular cancer	0.171	0.318	CtDrD
Vinblastine—ABCC6—Dactinomycin—testicular cancer	0.071	0.216	CbGbCtD
Vinblastine—ABCC6—Cisplatin—testicular cancer	0.0408	0.124	CbGbCtD
Vinblastine—ABCC6—Etoposide—testicular cancer	0.0401	0.122	CbGbCtD
Vinblastine—ABCC6—Doxorubicin—testicular cancer	0.0273	0.0833	CbGbCtD
Vinblastine—ABCC1—Dactinomycin—testicular cancer	0.0209	0.0639	CbGbCtD
Vinblastine—ABCC1—Epirubicin—testicular cancer	0.0152	0.0462	CbGbCtD
Vinblastine—NR5A1—corpus luteum—testicular cancer	0.0119	0.206	CbGeAlD
Vinblastine—ABCC1—Etoposide—testicular cancer	0.0118	0.036	CbGbCtD
Vinblastine—ABCB11—Doxorubicin—testicular cancer	0.0113	0.0346	CbGbCtD
Vinblastine—SLC22A2—Cisplatin—testicular cancer	0.0109	0.0332	CbGbCtD
Vinblastine—ABCC2—Carboplatin—testicular cancer	0.0104	0.0318	CbGbCtD
Vinblastine—NR5A1—seminiferous tubule of testis—testicular cancer	0.0101	0.174	CbGeAlD
Vinblastine—ABCC2—Cisplatin—testicular cancer	0.0089	0.0271	CbGbCtD
Vinblastine—ABCC2—Etoposide—testicular cancer	0.00875	0.0267	CbGbCtD
Vinblastine—ABCC1—Doxorubicin—testicular cancer	0.00806	0.0246	CbGbCtD
Vinblastine—ABCC1—Methotrexate—testicular cancer	0.00781	0.0238	CbGbCtD
Vinblastine—NR5A1—Ovarian Infertility Genes—DAZL—testicular cancer	0.00688	0.312	CbGpPWpGaD
Vinblastine—NR5A1—Transcriptional regulation of pluripotent stem cells—PRDM14—testicular cancer	0.00621	0.281	CbGpPWpGaD
Vinblastine—ABCC2—Doxorubicin—testicular cancer	0.00596	0.0182	CbGbCtD
Vinblastine—ABCC2—Methotrexate—testicular cancer	0.00578	0.0176	CbGbCtD
Vinblastine—ABCB1—Dactinomycin—testicular cancer	0.00505	0.0154	CbGbCtD
Vinblastine—CYP3A4—Ifosfamide—testicular cancer	0.00357	0.0109	CbGbCtD
Vinblastine—ABCB1—Cisplatin—testicular cancer	0.0029	0.00885	CbGbCtD
Vinblastine—ABCB1—Etoposide—testicular cancer	0.00285	0.0087	CbGbCtD
Vinblastine—ABCB1—Doxorubicin—testicular cancer	0.00194	0.00593	CbGbCtD
Vinblastine—ABCB1—Methotrexate—testicular cancer	0.00188	0.00575	CbGbCtD
Vinblastine—CYP2D6—Doxorubicin—testicular cancer	0.00183	0.00559	CbGbCtD
Vinblastine—CYP3A4—Etoposide—testicular cancer	0.00171	0.00521	CbGbCtD
Vinblastine—TUBD1—embryo—testicular cancer	0.00154	0.0266	CbGeAlD
Vinblastine—TUBD1—seminal vesicle—testicular cancer	0.00144	0.025	CbGeAlD
Vinblastine—ABCC6—Podofilox—Etoposide—testicular cancer	0.00138	1	CbGdCrCtD
Vinblastine—TUBE1—seminal vesicle—testicular cancer	0.00135	0.0234	CbGeAlD
Vinblastine—TUBG1—seminal vesicle—testicular cancer	0.00121	0.0209	CbGeAlD
Vinblastine—CYP3A4—Doxorubicin—testicular cancer	0.00117	0.00355	CbGbCtD
Vinblastine—TUBE1—gonad—testicular cancer	0.000978	0.0169	CbGeAlD
Vinblastine—TUBG1—gonad—testicular cancer	0.000875	0.0151	CbGeAlD
Vinblastine—NR5A1—gonad—testicular cancer	0.000854	0.0148	CbGeAlD
Vinblastine—TUBD1—female gonad—testicular cancer	0.000847	0.0147	CbGeAlD
Vinblastine—TUBE1—female gonad—testicular cancer	0.000794	0.0137	CbGeAlD
Vinblastine—TUBB8—testis—testicular cancer	0.000752	0.013	CbGeAlD
Vinblastine—TUBD1—testis—testicular cancer	0.000752	0.013	CbGeAlD
Vinblastine—TUBA1A—embryo—testicular cancer	0.000747	0.0129	CbGeAlD
Vinblastine—JUN—embryo—testicular cancer	0.000739	0.0128	CbGeAlD
Vinblastine—TUBG1—female gonad—testicular cancer	0.000711	0.0123	CbGeAlD
Vinblastine—TUBE1—testis—testicular cancer	0.000705	0.0122	CbGeAlD
Vinblastine—TUBA1A—seminal vesicle—testicular cancer	0.000701	0.0121	CbGeAlD
Vinblastine—JUN—seminal vesicle—testicular cancer	0.000694	0.012	CbGeAlD
Vinblastine—NR5A1—female gonad—testicular cancer	0.000694	0.012	CbGeAlD
Vinblastine—TUBB4A—embryo—testicular cancer	0.000638	0.011	CbGeAlD
Vinblastine—TUBG1—testis—testicular cancer	0.000631	0.0109	CbGeAlD
Vinblastine—NR5A1—testis—testicular cancer	0.000615	0.0106	CbGeAlD
Vinblastine—TUBB2B—seminal vesicle—testicular cancer	0.000579	0.01	CbGeAlD
Vinblastine—TUBB—seminal vesicle—testicular cancer	0.000548	0.00948	CbGeAlD
Vinblastine—TUBB2A—seminal vesicle—testicular cancer	0.000545	0.00943	CbGeAlD
Vinblastine—TUBD1—lymph node—testicular cancer	0.000545	0.00942	CbGeAlD
Vinblastine—TUBB6—seminal vesicle—testicular cancer	0.000538	0.0093	CbGeAlD
Vinblastine—TUBB3—testis—testicular cancer	0.000513	0.00887	CbGeAlD
Vinblastine—TUBE1—lymph node—testicular cancer	0.000511	0.00884	CbGeAlD
Vinblastine—TUBA1A—gonad—testicular cancer	0.000507	0.00877	CbGeAlD
Vinblastine—JUN—gonad—testicular cancer	0.000502	0.00868	CbGeAlD
Vinblastine—TUBB1—testis—testicular cancer	0.000501	0.00867	CbGeAlD
Vinblastine—TUBB4B—embryo—testicular cancer	0.000498	0.00861	CbGeAlD
Vinblastine—NR5A1—Developmental Biology—PRDM14—testicular cancer	0.000496	0.0225	CbGpPWpGaD
Vinblastine—TUBB4B—seminal vesicle—testicular cancer	0.000467	0.00808	CbGeAlD
Vinblastine—TUBG1—lymph node—testicular cancer	0.000457	0.00791	CbGeAlD
Vinblastine—TUBB4A—gonad—testicular cancer	0.000433	0.00749	CbGeAlD
Vinblastine—TUBB2B—gonad—testicular cancer	0.000419	0.00724	CbGeAlD
Vinblastine—TUBA1A—female gonad—testicular cancer	0.000412	0.00712	CbGeAlD
Vinblastine—JUN—female gonad—testicular cancer	0.000408	0.00705	CbGeAlD
Vinblastine—TUBB6—gonad—testicular cancer	0.000389	0.00672	CbGeAlD
Vinblastine—ABCB11—testis—testicular cancer	0.000387	0.0067	CbGeAlD
Vinblastine—TUBA1A—testis—testicular cancer	0.000365	0.00632	CbGeAlD
Vinblastine—JUN—testis—testicular cancer	0.000362	0.00626	CbGeAlD
Vinblastine—TUBB4A—female gonad—testicular cancer	0.000352	0.00609	CbGeAlD
Vinblastine—SLC22A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A6—testicular cancer	0.000351	0.0159	CbGpPWpGaD
Vinblastine—ABCC6—Transmembrane transport of small molecules—SLC2A6—testicular cancer	0.00035	0.0159	CbGpPWpGaD
Vinblastine—TUBB2B—female gonad—testicular cancer	0.00034	0.00588	CbGeAlD
Vinblastine—TUBB4B—gonad—testicular cancer	0.000338	0.00584	CbGeAlD
Vinblastine—ABCC1—seminal vesicle—testicular cancer	0.000333	0.00576	CbGeAlD
Vinblastine—TUBB—female gonad—testicular cancer	0.000322	0.00557	CbGeAlD
Vinblastine—TUBB2A—female gonad—testicular cancer	0.00032	0.00554	CbGeAlD
Vinblastine—TUBB6—female gonad—testicular cancer	0.000316	0.00546	CbGeAlD
Vinblastine—TUBB4A—testis—testicular cancer	0.000312	0.0054	CbGeAlD
Vinblastine—TUBB2B—testis—testicular cancer	0.000302	0.00522	CbGeAlD
Vinblastine—ABCC2—NRF2 pathway—SLC2A6—testicular cancer	0.000294	0.0133	CbGpPWpGaD
Vinblastine—TUBB—testis—testicular cancer	0.000285	0.00494	CbGeAlD
Vinblastine—TUBB2A—testis—testicular cancer	0.000284	0.00491	CbGeAlD
Vinblastine—TUBB6—testis—testicular cancer	0.00028	0.00484	CbGeAlD
Vinblastine—TUBB4B—female gonad—testicular cancer	0.000274	0.00475	CbGeAlD
Vinblastine—JUN—BCR signaling pathway—BCL10—testicular cancer	0.000265	0.012	CbGpPWpGaD
Vinblastine—TUBA1A—lymph node—testicular cancer	0.000265	0.00458	CbGeAlD
Vinblastine—JUN—lymph node—testicular cancer	0.000262	0.00453	CbGeAlD
Vinblastine—ABCC1—Arachidonic acid metabolism—HPGDS—testicular cancer	0.000248	0.0113	CbGpPWpGaD
Vinblastine—TUBB4B—testis—testicular cancer	0.000243	0.00421	CbGeAlD
Vinblastine—Haemoglobin—Bleomycin—testicular cancer	0.000235	0.00459	CcSEcCtD
Vinblastine—Haemorrhage—Bleomycin—testicular cancer	0.000234	0.00457	CcSEcCtD
Vinblastine—Hypoaesthesia—Bleomycin—testicular cancer	0.000232	0.00454	CcSEcCtD
Vinblastine—Ileus—Doxorubicin—testicular cancer	0.00023	0.0045	CcSEcCtD
Vinblastine—Nystagmus—Doxorubicin—testicular cancer	0.000228	0.00446	CcSEcCtD
Vinblastine—Convulsion—Chlorambucil—testicular cancer	0.000228	0.00445	CcSEcCtD
Vinblastine—Agranulocytosis—Dactinomycin—testicular cancer	0.000226	0.00443	CcSEcCtD
Vinblastine—TUBB4A—lymph node—testicular cancer	0.000226	0.00391	CbGeAlD
Vinblastine—TUBG1—Cell Cycle, Mitotic—MAD1L1—testicular cancer	0.000224	0.0101	CbGpPWpGaD
Vinblastine—Acute coronary syndrome—Ifosfamide—testicular cancer	0.000219	0.00429	CcSEcCtD
Vinblastine—TUBB2B—lymph node—testicular cancer	0.000219	0.00378	CbGeAlD
Vinblastine—Neuritis—Doxorubicin—testicular cancer	0.000218	0.00427	CcSEcCtD
Vinblastine—Myocardial infarction—Ifosfamide—testicular cancer	0.000218	0.00426	CcSEcCtD
Vinblastine—Neuropathy peripheral—Ifosfamide—testicular cancer	0.000218	0.00426	CcSEcCtD
Vinblastine—Pharyngitis—Dactinomycin—testicular cancer	0.000216	0.00423	CcSEcCtD
Vinblastine—Extravasation—Methotrexate—testicular cancer	0.000216	0.00422	CcSEcCtD
Vinblastine—Thrombocytopenia—Chlorambucil—testicular cancer	0.00021	0.00411	CcSEcCtD
Vinblastine—JUN—TCR Signaling Pathway—BCL10—testicular cancer	0.000209	0.00949	CbGpPWpGaD
Vinblastine—Agranulocytosis—Ifosfamide—testicular cancer	0.000207	0.00406	CcSEcCtD
Vinblastine—TUBB—lymph node—testicular cancer	0.000207	0.00358	CbGeAlD
Vinblastine—Alopecia—Bleomycin—testicular cancer	0.000206	0.00404	CcSEcCtD
Vinblastine—TUBB2A—lymph node—testicular cancer	0.000206	0.00356	CbGeAlD
Vinblastine—Anorexia—Chlorambucil—testicular cancer	0.000204	0.004	CcSEcCtD
Vinblastine—Pancytopenia—Cisplatin—testicular cancer	0.000204	0.00399	CcSEcCtD
Vinblastine—TUBB6—lymph node—testicular cancer	0.000203	0.00351	CbGeAlD
Vinblastine—Extravasation—Epirubicin—testicular cancer	0.000202	0.00394	CcSEcCtD
Vinblastine—Haemoglobin—Ifosfamide—testicular cancer	0.000201	0.00392	CcSEcCtD
Vinblastine—TUBG1—Cell Cycle—MAD1L1—testicular cancer	0.0002	0.00907	CbGpPWpGaD
Vinblastine—Haemorrhage—Ifosfamide—testicular cancer	0.0002	0.0039	CcSEcCtD
Vinblastine—JUN—B Cell Receptor Signaling Pathway—BCL10—testicular cancer	0.000197	0.00894	CbGpPWpGaD
Vinblastine—ABCC2—testis—testicular cancer	0.000197	0.00341	CbGeAlD
Vinblastine—ABCC1—female gonad—testicular cancer	0.000196	0.00338	CbGeAlD
Vinblastine—Rectal haemorrhage—Epirubicin—testicular cancer	0.000195	0.00381	CcSEcCtD
Vinblastine—TUBB2B—Transmembrane transport of small molecules—SLC2A6—testicular cancer	0.000194	0.00878	CbGpPWpGaD
Vinblastine—TUBB6—Transmembrane transport of small molecules—SLC2A6—testicular cancer	0.000194	0.00878	CbGpPWpGaD
Vinblastine—Cellulitis—Epirubicin—testicular cancer	0.000194	0.00378	CcSEcCtD
Vinblastine—Alopecia—Dactinomycin—testicular cancer	0.000192	0.00376	CcSEcCtD
Vinblastine—Acute coronary syndrome—Cisplatin—testicular cancer	0.000189	0.0037	CcSEcCtD
Vinblastine—Ill-defined disorder—Bleomycin—testicular cancer	0.000189	0.00369	CcSEcCtD
Vinblastine—Anaemia—Bleomycin—testicular cancer	0.000188	0.00368	CcSEcCtD
Vinblastine—Myocardial infarction—Cisplatin—testicular cancer	0.000188	0.00367	CcSEcCtD
Vinblastine—Neuropathy peripheral—Cisplatin—testicular cancer	0.000188	0.00367	CcSEcCtD
Vinblastine—TUBB3—Transmembrane transport of small molecules—SLC2A6—testicular cancer	0.000187	0.00848	CbGpPWpGaD
Vinblastine—Pancytopenia—Etoposide—testicular cancer	0.000187	0.00366	CcSEcCtD
Vinblastine—Extravasation—Doxorubicin—testicular cancer	0.000187	0.00365	CcSEcCtD
Vinblastine—Decreased appetite—Chlorambucil—testicular cancer	0.000186	0.00364	CcSEcCtD
Vinblastine—Bone pain—Epirubicin—testicular cancer	0.000184	0.00359	CcSEcCtD
Vinblastine—Malaise—Bleomycin—testicular cancer	0.000183	0.00359	CcSEcCtD
Vinblastine—Pain—Chlorambucil—testicular cancer	0.000183	0.00359	CcSEcCtD
Vinblastine—Leukopenia—Bleomycin—testicular cancer	0.000182	0.00356	CcSEcCtD
Vinblastine—TUBB2A—Transmembrane transport of small molecules—SLC2A6—testicular cancer	0.000181	0.00821	CbGpPWpGaD
Vinblastine—Rectal haemorrhage—Doxorubicin—testicular cancer	0.00018	0.00353	CcSEcCtD
Vinblastine—JUN—Osteopontin-mediated events—MMP2—testicular cancer	0.000179	0.00812	CbGpPWpGaD
Vinblastine—Cellulitis—Doxorubicin—testicular cancer	0.000179	0.0035	CcSEcCtD
Vinblastine—TUBB1—Transmembrane transport of small molecules—SLC2A6—testicular cancer	0.000177	0.00803	CbGpPWpGaD
Vinblastine—Feeling abnormal—Chlorambucil—testicular cancer	0.000177	0.00346	CcSEcCtD
Vinblastine—TUBB4B—lymph node—testicular cancer	0.000176	0.00305	CbGeAlD
Vinblastine—Alopecia—Ifosfamide—testicular cancer	0.000176	0.00345	CcSEcCtD
Vinblastine—Ill-defined disorder—Dactinomycin—testicular cancer	0.000176	0.00344	CcSEcCtD
Vinblastine—Gastrointestinal pain—Chlorambucil—testicular cancer	0.000175	0.00343	CcSEcCtD
Vinblastine—Anaemia—Dactinomycin—testicular cancer	0.000175	0.00343	CcSEcCtD
Vinblastine—ABCC1—testis—testicular cancer	0.000173	0.003	CbGeAlD
Vinblastine—Acute coronary syndrome—Etoposide—testicular cancer	0.000173	0.00339	CcSEcCtD
Vinblastine—Myocardial infarction—Etoposide—testicular cancer	0.000172	0.00337	CcSEcCtD
Vinblastine—Neuropathy peripheral—Etoposide—testicular cancer	0.000172	0.00337	CcSEcCtD
Vinblastine—Discomfort—Bleomycin—testicular cancer	0.000171	0.00334	CcSEcCtD
Vinblastine—Malaise—Dactinomycin—testicular cancer	0.000171	0.00334	CcSEcCtD
Vinblastine—Neoplasm—Methotrexate—testicular cancer	0.00017	0.00332	CcSEcCtD
Vinblastine—Bone pain—Doxorubicin—testicular cancer	0.00017	0.00332	CcSEcCtD
Vinblastine—Leukopenia—Dactinomycin—testicular cancer	0.00017	0.00332	CcSEcCtD
Vinblastine—Abdominal pain—Chlorambucil—testicular cancer	0.000169	0.00331	CcSEcCtD
Vinblastine—Agranulocytosis—Etoposide—testicular cancer	0.000164	0.00321	CcSEcCtD
Vinblastine—Thrombocytopenia—Bleomycin—testicular cancer	0.000162	0.00318	CcSEcCtD
Vinblastine—Ill-defined disorder—Ifosfamide—testicular cancer	0.000161	0.00315	CcSEcCtD
Vinblastine—Anaemia—Ifosfamide—testicular cancer	0.000161	0.00314	CcSEcCtD
Vinblastine—Discomfort—Dactinomycin—testicular cancer	0.000159	0.00312	CcSEcCtD
Vinblastine—SLC22A2—SLC-mediated transmembrane transport—SLC2A6—testicular cancer	0.000159	0.00722	CbGpPWpGaD
Vinblastine—Neoplasm—Epirubicin—testicular cancer	0.000159	0.00311	CcSEcCtD
Vinblastine—TUBB4A—Transmembrane transport of small molecules—SLC2A6—testicular cancer	0.000159	0.00721	CbGpPWpGaD
Vinblastine—Anorexia—Bleomycin—testicular cancer	0.000158	0.00309	CcSEcCtD
Vinblastine—Hypersensitivity—Chlorambucil—testicular cancer	0.000158	0.00309	CcSEcCtD
Vinblastine—NR5A1—Gene Expression—DNMT3L—testicular cancer	0.000157	0.00711	CbGpPWpGaD
Vinblastine—Hypoaesthesia—Etoposide—testicular cancer	0.000157	0.00307	CcSEcCtD
Vinblastine—Malaise—Ifosfamide—testicular cancer	0.000157	0.00306	CcSEcCtD
Vinblastine—Vertigo—Ifosfamide—testicular cancer	0.000156	0.00305	CcSEcCtD
Vinblastine—TUBG1—Cell Cycle, Mitotic—H2AFZ—testicular cancer	0.000156	0.00707	CbGpPWpGaD
Vinblastine—Leukopenia—Ifosfamide—testicular cancer	0.000156	0.00304	CcSEcCtD
Vinblastine—JUN—Validated transcriptional targets of AP1 family members Fra1 and Fra2—MMP2—testicular cancer	0.000155	0.00705	CbGpPWpGaD
Vinblastine—Asthenia—Chlorambucil—testicular cancer	0.000154	0.00301	CcSEcCtD
Vinblastine—Alopecia—Cisplatin—testicular cancer	0.000152	0.00297	CcSEcCtD
Vinblastine—Thrombocytopenia—Dactinomycin—testicular cancer	0.000152	0.00296	CcSEcCtD
Vinblastine—Convulsion—Ifosfamide—testicular cancer	0.000151	0.00294	CcSEcCtD
Vinblastine—Hypertension—Ifosfamide—testicular cancer	0.00015	0.00293	CcSEcCtD
Vinblastine—Paraesthesia—Bleomycin—testicular cancer	0.000149	0.00291	CcSEcCtD
Vinblastine—Phlebitis—Epirubicin—testicular cancer	0.000148	0.0029	CcSEcCtD
Vinblastine—Anorexia—Dactinomycin—testicular cancer	0.000148	0.00288	CcSEcCtD
Vinblastine—Neoplasm—Doxorubicin—testicular cancer	0.000147	0.00288	CcSEcCtD
Vinblastine—Diarrhoea—Chlorambucil—testicular cancer	0.000147	0.00287	CcSEcCtD
Vinblastine—Discomfort—Ifosfamide—testicular cancer	0.000146	0.00286	CcSEcCtD
Vinblastine—TUBB4B—Transmembrane transport of small molecules—SLC2A6—testicular cancer	0.000146	0.0066	CbGpPWpGaD
Vinblastine—ABCB1—embryo—testicular cancer	0.000145	0.0025	CbGeAlD
Vinblastine—Decreased appetite—Bleomycin—testicular cancer	0.000144	0.00282	CcSEcCtD
Vinblastine—ABCC2—lymph node—testicular cancer	0.000143	0.00247	CbGeAlD
Vinblastine—Pain—Bleomycin—testicular cancer	0.000142	0.00278	CcSEcCtD
Vinblastine—JUN—FGF signaling pathway—FGFR3—testicular cancer	0.000141	0.0064	CbGpPWpGaD
Vinblastine—TUBG1—Cell Cycle—H2AFZ—testicular cancer	0.000139	0.00632	CbGpPWpGaD
Vinblastine—Alopecia—Etoposide—testicular cancer	0.000139	0.00272	CcSEcCtD
Vinblastine—Cerebrovascular accident—Methotrexate—testicular cancer	0.000139	0.00272	CcSEcCtD
Vinblastine—Ill-defined disorder—Cisplatin—testicular cancer	0.000139	0.00272	CcSEcCtD
Vinblastine—Thrombocytopenia—Ifosfamide—testicular cancer	0.000139	0.00272	CcSEcCtD
Vinblastine—Anaemia—Cisplatin—testicular cancer	0.000138	0.00271	CcSEcCtD
Vinblastine—Phlebitis—Doxorubicin—testicular cancer	0.000137	0.00268	CcSEcCtD
Vinblastine—Feeling abnormal—Bleomycin—testicular cancer	0.000137	0.00267	CcSEcCtD
Vinblastine—Vomiting—Chlorambucil—testicular cancer	0.000136	0.00267	CcSEcCtD
Vinblastine—ABCB1—seminal vesicle—testicular cancer	0.000136	0.00235	CbGeAlD
Vinblastine—Anorexia—Ifosfamide—testicular cancer	0.000135	0.00264	CcSEcCtD
Vinblastine—Malaise—Cisplatin—testicular cancer	0.000135	0.00264	CcSEcCtD
Vinblastine—Decreased appetite—Dactinomycin—testicular cancer	0.000135	0.00263	CcSEcCtD
Vinblastine—Leukopenia—Cisplatin—testicular cancer	0.000134	0.00262	CcSEcCtD
Vinblastine—Pain—Dactinomycin—testicular cancer	0.000132	0.00259	CcSEcCtD
Vinblastine—Cerebrovascular accident—Epirubicin—testicular cancer	0.00013	0.00255	CcSEcCtD
Vinblastine—Convulsion—Cisplatin—testicular cancer	0.00013	0.00254	CcSEcCtD
Vinblastine—Feeling abnormal—Dactinomycin—testicular cancer	0.000128	0.00249	CcSEcCtD
Vinblastine—Nausea—Chlorambucil—testicular cancer	0.000127	0.00249	CcSEcCtD
Vinblastine—Paraesthesia—Ifosfamide—testicular cancer	0.000127	0.00249	CcSEcCtD
Vinblastine—Ill-defined disorder—Etoposide—testicular cancer	0.000127	0.00249	CcSEcCtD
Vinblastine—Anaemia—Etoposide—testicular cancer	0.000127	0.00248	CcSEcCtD
Vinblastine—Gastrointestinal pain—Dactinomycin—testicular cancer	0.000127	0.00247	CcSEcCtD
Vinblastine—Discomfort—Cisplatin—testicular cancer	0.000126	0.00246	CcSEcCtD
Vinblastine—ABCC1—lymph node—testicular cancer	0.000126	0.00217	CbGeAlD
Vinblastine—Malaise—Etoposide—testicular cancer	0.000124	0.00242	CcSEcCtD
Vinblastine—Vertigo—Etoposide—testicular cancer	0.000123	0.00241	CcSEcCtD
Vinblastine—Decreased appetite—Ifosfamide—testicular cancer	0.000123	0.00241	CcSEcCtD
Vinblastine—Leukopenia—Etoposide—testicular cancer	0.000123	0.0024	CcSEcCtD
Vinblastine—Abdominal pain—Dactinomycin—testicular cancer	0.000122	0.00239	CcSEcCtD
Vinblastine—Hypersensitivity—Bleomycin—testicular cancer	0.000122	0.00239	CcSEcCtD
Vinblastine—JUN—Fc epsilon receptor (FCERI) signaling—BCL10—testicular cancer	0.000122	0.00553	CbGpPWpGaD
Vinblastine—JUN—Senescence-Associated Secretory Phenotype (SASP)—H2AFZ—testicular cancer	0.000121	0.0055	CbGpPWpGaD
Vinblastine—Pain—Ifosfamide—testicular cancer	0.000121	0.00237	CcSEcCtD
Vinblastine—Constipation—Ifosfamide—testicular cancer	0.000121	0.00237	CcSEcCtD
Vinblastine—Cerebrovascular accident—Doxorubicin—testicular cancer	0.000121	0.00236	CcSEcCtD
Vinblastine—Thrombocytopenia—Cisplatin—testicular cancer	0.00012	0.00234	CcSEcCtD
Vinblastine—Asthenia—Bleomycin—testicular cancer	0.000119	0.00233	CcSEcCtD
Vinblastine—Convulsion—Etoposide—testicular cancer	0.000119	0.00233	CcSEcCtD
Vinblastine—Hypertension—Etoposide—testicular cancer	0.000118	0.00232	CcSEcCtD
Vinblastine—Feeling abnormal—Ifosfamide—testicular cancer	0.000117	0.00229	CcSEcCtD
Vinblastine—Anorexia—Cisplatin—testicular cancer	0.000117	0.00228	CcSEcCtD
Vinblastine—Gastrointestinal pain—Ifosfamide—testicular cancer	0.000116	0.00227	CcSEcCtD
Vinblastine—Discomfort—Etoposide—testicular cancer	0.000115	0.00226	CcSEcCtD
Vinblastine—Hypersensitivity—Dactinomycin—testicular cancer	0.000114	0.00223	CcSEcCtD
Vinblastine—Abdominal pain—Ifosfamide—testicular cancer	0.000112	0.00219	CcSEcCtD
Vinblastine—Pancytopenia—Methotrexate—testicular cancer	0.000112	0.00219	CcSEcCtD
Vinblastine—TUBA1A—Cell Cycle, Mitotic—MAD1L1—testicular cancer	0.000112	0.00507	CbGpPWpGaD
Vinblastine—Asthenia—Dactinomycin—testicular cancer	0.000111	0.00217	CcSEcCtD
Vinblastine—CYP2D6—female gonad—testicular cancer	0.000111	0.00192	CbGeAlD
Vinblastine—JUN—Oxidative Stress Induced Senescence—H2AFZ—testicular cancer	0.00011	0.00498	CbGpPWpGaD
Vinblastine—Paraesthesia—Cisplatin—testicular cancer	0.00011	0.00215	CcSEcCtD
Vinblastine—Thrombocytopenia—Etoposide—testicular cancer	0.00011	0.00214	CcSEcCtD
Vinblastine—Angina pectoris—Epirubicin—testicular cancer	0.000108	0.0021	CcSEcCtD
Vinblastine—JUN—ATF-2 transcription factor network—MMP2—testicular cancer	0.000107	0.00485	CbGpPWpGaD
Vinblastine—Anorexia—Etoposide—testicular cancer	0.000107	0.00209	CcSEcCtD
Vinblastine—Decreased appetite—Cisplatin—testicular cancer	0.000106	0.00208	CcSEcCtD
Vinblastine—Diarrhoea—Dactinomycin—testicular cancer	0.000106	0.00207	CcSEcCtD
Vinblastine—Vomiting—Bleomycin—testicular cancer	0.000105	0.00206	CcSEcCtD
Vinblastine—Depression—Methotrexate—testicular cancer	0.000105	0.00205	CcSEcCtD
Vinblastine—Pancytopenia—Epirubicin—testicular cancer	0.000105	0.00205	CcSEcCtD
Vinblastine—Pain—Cisplatin—testicular cancer	0.000105	0.00204	CcSEcCtD
Vinblastine—Hypersensitivity—Ifosfamide—testicular cancer	0.000104	0.00204	CcSEcCtD
Vinblastine—JUN—Integrated Pancreatic Cancer Pathway—HPGDS—testicular cancer	0.000103	0.00466	CbGpPWpGaD
Vinblastine—Asthenia—Ifosfamide—testicular cancer	0.000102	0.00199	CcSEcCtD
Vinblastine—Feeling abnormal—Cisplatin—testicular cancer	0.000101	0.00197	CcSEcCtD
Vinblastine—Paraesthesia—Etoposide—testicular cancer	0.000101	0.00197	CcSEcCtD
Vinblastine—JUN—LPA receptor mediated events—MMP2—testicular cancer	0.0001	0.00455	CbGpPWpGaD
Vinblastine—TUBA1A—Cell Cycle—MAD1L1—testicular cancer	9.99e-05	0.00453	CbGpPWpGaD
Vinblastine—Angina pectoris—Doxorubicin—testicular cancer	9.95e-05	0.00195	CcSEcCtD
Vinblastine—Nausea—Bleomycin—testicular cancer	9.86e-05	0.00193	CcSEcCtD
Vinblastine—CYP2D6—testis—testicular cancer	9.84e-05	0.0017	CbGeAlD
Vinblastine—Vomiting—Dactinomycin—testicular cancer	9.84e-05	0.00192	CcSEcCtD
Vinblastine—ABCB1—gonad—testicular cancer	9.82e-05	0.0017	CbGeAlD
Vinblastine—Agranulocytosis—Methotrexate—testicular cancer	9.82e-05	0.00192	CcSEcCtD
Vinblastine—JUN—AGE/RAGE pathway—MMP2—testicular cancer	9.79e-05	0.00444	CbGpPWpGaD
Vinblastine—Decreased appetite—Etoposide—testicular cancer	9.74e-05	0.0019	CcSEcCtD
Vinblastine—Diarrhoea—Ifosfamide—testicular cancer	9.7e-05	0.0019	CcSEcCtD
Vinblastine—Pancytopenia—Doxorubicin—testicular cancer	9.7e-05	0.0019	CcSEcCtD
Vinblastine—Neuropathy peripheral—Epirubicin—testicular cancer	9.65e-05	0.00189	CcSEcCtD
Vinblastine—Pain—Etoposide—testicular cancer	9.58e-05	0.00187	CcSEcCtD
Vinblastine—Constipation—Etoposide—testicular cancer	9.58e-05	0.00187	CcSEcCtD
Vinblastine—Haemoglobin—Methotrexate—testicular cancer	9.49e-05	0.00186	CcSEcCtD
Vinblastine—Haemorrhage—Methotrexate—testicular cancer	9.44e-05	0.00185	CcSEcCtD
Vinblastine—ABCC2—Transmembrane transport of small molecules—SLC2A6—testicular cancer	9.4e-05	0.00426	CbGpPWpGaD
Vinblastine—Dizziness—Ifosfamide—testicular cancer	9.38e-05	0.00183	CcSEcCtD
Vinblastine—Pharyngitis—Methotrexate—testicular cancer	9.37e-05	0.00183	CcSEcCtD
Vinblastine—ABCC1—Transmembrane transport of small molecules—SLC2A6—testicular cancer	9.29e-05	0.00421	CbGpPWpGaD
Vinblastine—Feeling abnormal—Etoposide—testicular cancer	9.23e-05	0.00181	CcSEcCtD
Vinblastine—Nausea—Dactinomycin—testicular cancer	9.19e-05	0.0018	CcSEcCtD
Vinblastine—Agranulocytosis—Epirubicin—testicular cancer	9.19e-05	0.0018	CcSEcCtD
Vinblastine—Gastrointestinal pain—Etoposide—testicular cancer	9.16e-05	0.00179	CcSEcCtD
Vinblastine—JUN—Integrated Breast Cancer Pathway—STK11—testicular cancer	9.02e-05	0.00409	CbGpPWpGaD
Vinblastine—Vomiting—Ifosfamide—testicular cancer	9.02e-05	0.00176	CcSEcCtD
Vinblastine—Hypersensitivity—Cisplatin—testicular cancer	9.01e-05	0.00176	CcSEcCtD
Vinblastine—Neuropathy peripheral—Doxorubicin—testicular cancer	8.93e-05	0.00175	CcSEcCtD
Vinblastine—TUBB—Cell Cycle, Mitotic—MAD1L1—testicular cancer	8.91e-05	0.00404	CbGpPWpGaD
Vinblastine—Haemoglobin—Epirubicin—testicular cancer	8.88e-05	0.00174	CcSEcCtD
Vinblastine—Abdominal pain—Etoposide—testicular cancer	8.85e-05	0.00173	CcSEcCtD
Vinblastine—Haemorrhage—Epirubicin—testicular cancer	8.84e-05	0.00173	CcSEcCtD
Vinblastine—Hypoaesthesia—Epirubicin—testicular cancer	8.79e-05	0.00172	CcSEcCtD
Vinblastine—Asthenia—Cisplatin—testicular cancer	8.77e-05	0.00172	CcSEcCtD
Vinblastine—Pharyngitis—Epirubicin—testicular cancer	8.77e-05	0.00172	CcSEcCtD
Vinblastine—Agranulocytosis—Doxorubicin—testicular cancer	8.5e-05	0.00166	CcSEcCtD
Vinblastine—Nausea—Ifosfamide—testicular cancer	8.42e-05	0.00165	CcSEcCtD
Vinblastine—JUN—Regulation of nuclear beta catenin signaling and target gene transcription—MMP2—testicular cancer	8.39e-05	0.0038	CbGpPWpGaD
Vinblastine—Diarrhoea—Cisplatin—testicular cancer	8.36e-05	0.00164	CcSEcCtD
Vinblastine—Alopecia—Methotrexate—testicular cancer	8.34e-05	0.00163	CcSEcCtD
Vinblastine—Hypersensitivity—Etoposide—testicular cancer	8.25e-05	0.00161	CcSEcCtD
Vinblastine—Haemoglobin—Doxorubicin—testicular cancer	8.22e-05	0.00161	CcSEcCtD
Vinblastine—Haemorrhage—Doxorubicin—testicular cancer	8.18e-05	0.0016	CcSEcCtD
Vinblastine—Hypoaesthesia—Doxorubicin—testicular cancer	8.14e-05	0.00159	CcSEcCtD
Vinblastine—Pharyngitis—Doxorubicin—testicular cancer	8.11e-05	0.00159	CcSEcCtD
Vinblastine—SLC22A2—Transmembrane transport of small molecules—SLC2A6—testicular cancer	8.09e-05	0.00367	CbGpPWpGaD
Vinblastine—Asthenia—Etoposide—testicular cancer	8.04e-05	0.00157	CcSEcCtD
Vinblastine—ABCB1—female gonad—testicular cancer	7.98e-05	0.00138	CbGeAlD
Vinblastine—TUBB—Cell Cycle—MAD1L1—testicular cancer	7.96e-05	0.00361	CbGpPWpGaD
Vinblastine—Alopecia—Epirubicin—testicular cancer	7.81e-05	0.00153	CcSEcCtD
Vinblastine—TUBA1A—Cell Cycle, Mitotic—H2AFZ—testicular cancer	7.79e-05	0.00353	CbGpPWpGaD
Vinblastine—Vomiting—Cisplatin—testicular cancer	7.77e-05	0.00152	CcSEcCtD
Vinblastine—JUN—Cellular Senescence—H2AFZ—testicular cancer	7.68e-05	0.00348	CbGpPWpGaD
Vinblastine—Diarrhoea—Etoposide—testicular cancer	7.66e-05	0.0015	CcSEcCtD
Vinblastine—Ill-defined disorder—Methotrexate—testicular cancer	7.63e-05	0.00149	CcSEcCtD
Vinblastine—Anaemia—Methotrexate—testicular cancer	7.6e-05	0.00149	CcSEcCtD
Vinblastine—JUN—Integrated Pancreatic Cancer Pathway—STK11—testicular cancer	7.48e-05	0.00339	CbGpPWpGaD
Vinblastine—Malaise—Methotrexate—testicular cancer	7.41e-05	0.00145	CcSEcCtD
Vinblastine—Dizziness—Etoposide—testicular cancer	7.41e-05	0.00145	CcSEcCtD
Vinblastine—Vertigo—Methotrexate—testicular cancer	7.38e-05	0.00144	CcSEcCtD
Vinblastine—TUBB4A—Cell Cycle, Mitotic—MAD1L1—testicular cancer	7.38e-05	0.00335	CbGpPWpGaD
Vinblastine—Leukopenia—Methotrexate—testicular cancer	7.36e-05	0.00144	CcSEcCtD
Vinblastine—JUN—Fc epsilon receptor (FCERI) signaling—KITLG—testicular cancer	7.35e-05	0.00333	CbGpPWpGaD
Vinblastine—Nausea—Cisplatin—testicular cancer	7.26e-05	0.00142	CcSEcCtD
Vinblastine—Alopecia—Doxorubicin—testicular cancer	7.22e-05	0.00141	CcSEcCtD
Vinblastine—Ill-defined disorder—Epirubicin—testicular cancer	7.14e-05	0.0014	CcSEcCtD
Vinblastine—Convulsion—Methotrexate—testicular cancer	7.12e-05	0.00139	CcSEcCtD
Vinblastine—Vomiting—Etoposide—testicular cancer	7.12e-05	0.00139	CcSEcCtD
Vinblastine—Anaemia—Epirubicin—testicular cancer	7.11e-05	0.00139	CcSEcCtD
Vinblastine—ABCB1—testis—testicular cancer	7.08e-05	0.00122	CbGeAlD
Vinblastine—Headache—Etoposide—testicular cancer	7.02e-05	0.00137	CcSEcCtD
Vinblastine—TUBA1A—Cell Cycle—H2AFZ—testicular cancer	6.97e-05	0.00316	CbGpPWpGaD
Vinblastine—Malaise—Epirubicin—testicular cancer	6.94e-05	0.00136	CcSEcCtD
Vinblastine—Discomfort—Methotrexate—testicular cancer	6.91e-05	0.00135	CcSEcCtD
Vinblastine—Vertigo—Epirubicin—testicular cancer	6.91e-05	0.00135	CcSEcCtD
Vinblastine—Leukopenia—Epirubicin—testicular cancer	6.89e-05	0.00135	CcSEcCtD
Vinblastine—TUBB4B—Cell Cycle, Mitotic—MAD1L1—testicular cancer	6.75e-05	0.00306	CbGpPWpGaD
Vinblastine—Convulsion—Epirubicin—testicular cancer	6.66e-05	0.0013	CcSEcCtD
Vinblastine—Nausea—Etoposide—testicular cancer	6.65e-05	0.0013	CcSEcCtD
Vinblastine—Hypertension—Epirubicin—testicular cancer	6.64e-05	0.0013	CcSEcCtD
Vinblastine—Ill-defined disorder—Doxorubicin—testicular cancer	6.6e-05	0.00129	CcSEcCtD
Vinblastine—TUBB4A—Cell Cycle—MAD1L1—testicular cancer	6.6e-05	0.00299	CbGpPWpGaD
Vinblastine—Anaemia—Doxorubicin—testicular cancer	6.58e-05	0.00129	CcSEcCtD
Vinblastine—Thrombocytopenia—Methotrexate—testicular cancer	6.57e-05	0.00128	CcSEcCtD
Vinblastine—Discomfort—Epirubicin—testicular cancer	6.47e-05	0.00127	CcSEcCtD
Vinblastine—Malaise—Doxorubicin—testicular cancer	6.42e-05	0.00126	CcSEcCtD
Vinblastine—Vertigo—Doxorubicin—testicular cancer	6.39e-05	0.00125	CcSEcCtD
Vinblastine—Anorexia—Methotrexate—testicular cancer	6.39e-05	0.00125	CcSEcCtD
Vinblastine—Leukopenia—Doxorubicin—testicular cancer	6.37e-05	0.00125	CcSEcCtD
Vinblastine—TUBB—Cell Cycle, Mitotic—H2AFZ—testicular cancer	6.21e-05	0.00281	CbGpPWpGaD
Vinblastine—Convulsion—Doxorubicin—testicular cancer	6.17e-05	0.00121	CcSEcCtD
Vinblastine—Thrombocytopenia—Epirubicin—testicular cancer	6.15e-05	0.0012	CcSEcCtD
Vinblastine—Hypertension—Doxorubicin—testicular cancer	6.14e-05	0.0012	CcSEcCtD
Vinblastine—TUBB4B—Cell Cycle—MAD1L1—testicular cancer	6.04e-05	0.00274	CbGpPWpGaD
Vinblastine—Paraesthesia—Methotrexate—testicular cancer	6.02e-05	0.00118	CcSEcCtD
Vinblastine—Discomfort—Doxorubicin—testicular cancer	5.99e-05	0.00117	CcSEcCtD
Vinblastine—Anorexia—Epirubicin—testicular cancer	5.98e-05	0.00117	CcSEcCtD
Vinblastine—NR5A1—Developmental Biology—MMP2—testicular cancer	5.97e-05	0.00271	CbGpPWpGaD
Vinblastine—Decreased appetite—Methotrexate—testicular cancer	5.83e-05	0.00114	CcSEcCtD
Vinblastine—JUN—Cellular responses to stress—H2AFZ—testicular cancer	5.8e-05	0.00263	CbGpPWpGaD
Vinblastine—Pain—Methotrexate—testicular cancer	5.74e-05	0.00112	CcSEcCtD
Vinblastine—Thrombocytopenia—Doxorubicin—testicular cancer	5.69e-05	0.00111	CcSEcCtD
Vinblastine—Paraesthesia—Epirubicin—testicular cancer	5.64e-05	0.0011	CcSEcCtD
Vinblastine—TUBB—Cell Cycle—H2AFZ—testicular cancer	5.55e-05	0.00252	CbGpPWpGaD
Vinblastine—Anorexia—Doxorubicin—testicular cancer	5.54e-05	0.00108	CcSEcCtD
Vinblastine—Feeling abnormal—Methotrexate—testicular cancer	5.53e-05	0.00108	CcSEcCtD
Vinblastine—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—KIT—testicular cancer	5.51e-05	0.0025	CbGpPWpGaD
Vinblastine—NR5A1—Gene Expression—H2AFZ—testicular cancer	5.49e-05	0.00249	CbGpPWpGaD
Vinblastine—Gastrointestinal pain—Methotrexate—testicular cancer	5.49e-05	0.00107	CcSEcCtD
Vinblastine—JUN—Fc epsilon receptor (FCERI) signaling—FGFR3—testicular cancer	5.46e-05	0.00248	CbGpPWpGaD
Vinblastine—Decreased appetite—Epirubicin—testicular cancer	5.46e-05	0.00107	CcSEcCtD
Vinblastine—Pain—Epirubicin—testicular cancer	5.37e-05	0.00105	CcSEcCtD
Vinblastine—Constipation—Epirubicin—testicular cancer	5.37e-05	0.00105	CcSEcCtD
Vinblastine—JUN—Direct p53 effectors—MMP2—testicular cancer	5.36e-05	0.00243	CbGpPWpGaD
Vinblastine—Abdominal pain—Methotrexate—testicular cancer	5.3e-05	0.00104	CcSEcCtD
Vinblastine—Paraesthesia—Doxorubicin—testicular cancer	5.22e-05	0.00102	CcSEcCtD
Vinblastine—Feeling abnormal—Epirubicin—testicular cancer	5.17e-05	0.00101	CcSEcCtD
Vinblastine—TUBB4A—Cell Cycle, Mitotic—H2AFZ—testicular cancer	5.14e-05	0.00233	CbGpPWpGaD
Vinblastine—Gastrointestinal pain—Epirubicin—testicular cancer	5.13e-05	0.001	CcSEcCtD
Vinblastine—ABCB1—lymph node—testicular cancer	5.13e-05	0.000888	CbGeAlD
Vinblastine—Decreased appetite—Doxorubicin—testicular cancer	5.05e-05	0.000988	CcSEcCtD
Vinblastine—JUN—Fc epsilon receptor (FCERI) signaling—KIT—testicular cancer	5.02e-05	0.00227	CbGpPWpGaD
Vinblastine—Constipation—Doxorubicin—testicular cancer	4.97e-05	0.000972	CcSEcCtD
Vinblastine—Pain—Doxorubicin—testicular cancer	4.97e-05	0.000972	CcSEcCtD
Vinblastine—Abdominal pain—Epirubicin—testicular cancer	4.96e-05	0.000971	CcSEcCtD
Vinblastine—Hypersensitivity—Methotrexate—testicular cancer	4.94e-05	0.000967	CcSEcCtD
Vinblastine—Asthenia—Methotrexate—testicular cancer	4.81e-05	0.000941	CcSEcCtD
Vinblastine—Feeling abnormal—Doxorubicin—testicular cancer	4.79e-05	0.000936	CcSEcCtD
Vinblastine—Gastrointestinal pain—Doxorubicin—testicular cancer	4.75e-05	0.000929	CcSEcCtD
Vinblastine—JUN—Innate Immune System—BCL10—testicular cancer	4.74e-05	0.00215	CbGpPWpGaD
Vinblastine—ABCB11—Metabolism of lipids and lipoproteins—HPGDS—testicular cancer	4.72e-05	0.00214	CbGpPWpGaD
Vinblastine—TUBB4B—Cell Cycle, Mitotic—H2AFZ—testicular cancer	4.71e-05	0.00213	CbGpPWpGaD
Vinblastine—Hypersensitivity—Epirubicin—testicular cancer	4.63e-05	0.000905	CcSEcCtD
Vinblastine—TUBB4A—Cell Cycle—H2AFZ—testicular cancer	4.6e-05	0.00209	CbGpPWpGaD
Vinblastine—Abdominal pain—Doxorubicin—testicular cancer	4.59e-05	0.000898	CcSEcCtD
Vinblastine—Diarrhoea—Methotrexate—testicular cancer	4.59e-05	0.000898	CcSEcCtD
Vinblastine—Asthenia—Epirubicin—testicular cancer	4.5e-05	0.000881	CcSEcCtD
Vinblastine—Dizziness—Methotrexate—testicular cancer	4.44e-05	0.000868	CcSEcCtD
Vinblastine—ABCB1—Transmembrane transport of small molecules—SLC2A6—testicular cancer	4.42e-05	0.002	CbGpPWpGaD
Vinblastine—Diarrhoea—Epirubicin—testicular cancer	4.3e-05	0.00084	CcSEcCtD
Vinblastine—Hypersensitivity—Doxorubicin—testicular cancer	4.28e-05	0.000837	CcSEcCtD
Vinblastine—Vomiting—Methotrexate—testicular cancer	4.27e-05	0.000834	CcSEcCtD
Vinblastine—TUBB4B—Cell Cycle—H2AFZ—testicular cancer	4.21e-05	0.00191	CbGpPWpGaD
Vinblastine—Headache—Methotrexate—testicular cancer	4.2e-05	0.000822	CcSEcCtD
Vinblastine—Asthenia—Doxorubicin—testicular cancer	4.17e-05	0.000815	CcSEcCtD
Vinblastine—Dizziness—Epirubicin—testicular cancer	4.15e-05	0.000812	CcSEcCtD
Vinblastine—CYP2D6—Biological oxidations—HPGDS—testicular cancer	4.14e-05	0.00188	CbGpPWpGaD
Vinblastine—ABCB1—Integrated Pancreatic Cancer Pathway—HPGDS—testicular cancer	4.04e-05	0.00183	CbGpPWpGaD
Vinblastine—Vomiting—Epirubicin—testicular cancer	3.99e-05	0.000781	CcSEcCtD
Vinblastine—Nausea—Methotrexate—testicular cancer	3.98e-05	0.000779	CcSEcCtD
Vinblastine—Diarrhoea—Doxorubicin—testicular cancer	3.97e-05	0.000777	CcSEcCtD
Vinblastine—Headache—Epirubicin—testicular cancer	3.93e-05	0.000769	CcSEcCtD
Vinblastine—Dizziness—Doxorubicin—testicular cancer	3.84e-05	0.000751	CcSEcCtD
Vinblastine—Nausea—Epirubicin—testicular cancer	3.73e-05	0.000729	CcSEcCtD
Vinblastine—Vomiting—Doxorubicin—testicular cancer	3.69e-05	0.000722	CcSEcCtD
Vinblastine—JUN—Signaling Pathways—INSL3—testicular cancer	3.65e-05	0.00166	CbGpPWpGaD
Vinblastine—Headache—Doxorubicin—testicular cancer	3.64e-05	0.000712	CcSEcCtD
Vinblastine—ABCC1—Metabolism of lipids and lipoproteins—HPGDS—testicular cancer	3.55e-05	0.00161	CbGpPWpGaD
Vinblastine—Nausea—Doxorubicin—testicular cancer	3.45e-05	0.000675	CcSEcCtD
Vinblastine—TUBA1A—Metabolism of proteins—MMP2—testicular cancer	3.23e-05	0.00146	CbGpPWpGaD
Vinblastine—ABCB1—Integrated Pancreatic Cancer Pathway—STK11—testicular cancer	2.94e-05	0.00133	CbGpPWpGaD
Vinblastine—JUN—Innate Immune System—KITLG—testicular cancer	2.86e-05	0.00129	CbGpPWpGaD
Vinblastine—JUN—Immune System—BCL10—testicular cancer	2.76e-05	0.00125	CbGpPWpGaD
Vinblastine—CYP3A4—Biological oxidations—HPGDS—testicular cancer	2.71e-05	0.00123	CbGpPWpGaD
Vinblastine—TUBB2B—Metabolism of proteins—MMP2—testicular cancer	2.6e-05	0.00118	CbGpPWpGaD
Vinblastine—TUBB6—Metabolism of proteins—MMP2—testicular cancer	2.6e-05	0.00118	CbGpPWpGaD
Vinblastine—TUBB3—Metabolism of proteins—MMP2—testicular cancer	2.51e-05	0.00114	CbGpPWpGaD
Vinblastine—TUBB2A—Metabolism of proteins—MMP2—testicular cancer	2.43e-05	0.0011	CbGpPWpGaD
Vinblastine—TUBB1—Metabolism of proteins—MMP2—testicular cancer	2.38e-05	0.00108	CbGpPWpGaD
Vinblastine—TUBB4A—Metabolism of proteins—MMP2—testicular cancer	2.13e-05	0.000967	CbGpPWpGaD
Vinblastine—JUN—Innate Immune System—FGFR3—testicular cancer	2.12e-05	0.000962	CbGpPWpGaD
Vinblastine—ABCB11—Metabolism—HPGDS—testicular cancer	2.1e-05	0.000953	CbGpPWpGaD
Vinblastine—TUBB4B—Metabolism of proteins—MMP2—testicular cancer	1.95e-05	0.000884	CbGpPWpGaD
Vinblastine—JUN—Innate Immune System—KIT—testicular cancer	1.95e-05	0.000884	CbGpPWpGaD
Vinblastine—JUN—Immune System—KITLG—testicular cancer	1.66e-05	0.000754	CbGpPWpGaD
Vinblastine—ABCC1—Metabolism—HPGDS—testicular cancer	1.58e-05	0.000716	CbGpPWpGaD
Vinblastine—ABCB11—Metabolism—STK11—testicular cancer	1.53e-05	0.000693	CbGpPWpGaD
Vinblastine—ABCC1—Disease—H2AFZ—testicular cancer	1.38e-05	0.000625	CbGpPWpGaD
Vinblastine—SLC22A2—Metabolism—HPGDS—testicular cancer	1.38e-05	0.000624	CbGpPWpGaD
Vinblastine—ABCC1—Disease—KITLG—testicular cancer	1.27e-05	0.000575	CbGpPWpGaD
Vinblastine—JUN—Immune System—FGFR3—testicular cancer	1.24e-05	0.00056	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—H2AFZ—testicular cancer	1.17e-05	0.00053	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—STK11—testicular cancer	1.16e-05	0.000527	CbGpPWpGaD
Vinblastine—ABCC1—Metabolism—STK11—testicular cancer	1.15e-05	0.00052	CbGpPWpGaD
Vinblastine—JUN—Immune System—KIT—testicular cancer	1.14e-05	0.000515	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—KITLG—testicular cancer	1.08e-05	0.000488	CbGpPWpGaD
Vinblastine—SLC22A2—Metabolism—STK11—testicular cancer	1e-05	0.000453	CbGpPWpGaD
Vinblastine—ABCC1—Disease—FGFR3—testicular cancer	9.43e-06	0.000427	CbGpPWpGaD
Vinblastine—ABCC1—Disease—KIT—testicular cancer	8.65e-06	0.000392	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—FGFR3—testicular cancer	7.99e-06	0.000362	CbGpPWpGaD
Vinblastine—ABCB1—Metabolism—HPGDS—testicular cancer	7.52e-06	0.000341	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—KIT—testicular cancer	7.34e-06	0.000333	CbGpPWpGaD
Vinblastine—CYP2D6—Metabolism—HPGDS—testicular cancer	7.08e-06	0.000321	CbGpPWpGaD
Vinblastine—ABCB1—Metabolism—STK11—testicular cancer	5.46e-06	0.000248	CbGpPWpGaD
Vinblastine—CYP2D6—Metabolism—STK11—testicular cancer	5.15e-06	0.000233	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—HPGDS—testicular cancer	4.63e-06	0.00021	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—STK11—testicular cancer	3.36e-06	0.000153	CbGpPWpGaD
